Works matching IS 14741776 AND DT 2004 AND VI 3 AND IP 8

Results: 20

From the analyst's couch: Statin switch to OTC.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 641, doi. 10.1038/nrd1471

By:

Link, Martyn

Publication type:

Article

Mid-year at the FDA highlights permanentproblem.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 637, doi. 10.1038/nrd1486

By:

Howard, Ken

Publication type:

Article

Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 695, doi. 10.1038/nrd1469

By:

Shi, Yuguang;
Burn, Paul

Publication type:

Article

Can the pharmaceutical industry reduce attrition rates?

Published in:

2004

By:

Kola, Ismail;
Landis, John

Publication type:

review

Calls for full disclosure of clinical trials.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 635, doi. 10.1038/nrd1485

By:

Frantz, Simon

Publication type:

Article

Recombinant biologics for treatment of bleeding disorders.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 684, doi. 10.1038/nrd1443

By:

Bishop, Paul;
Lawson, Jeff

Publication type:

Article

Fresh from the pipeline: Tiotropium bromide.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 643, doi. 10.1038/nrd1472

By:

Mundy, Cynthia;
Kirkpatrick, Peter

Publication type:

Article

Case history: A new oral anticoagulant: the 50-year challenge.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 649, doi. 10.1038/nrd1466

By:

Gustafsson, David;
Bylund, Ruth;
Antonsson, Thomas;
Nilsson, Ingemar;
Nyström, Jan-Erik;
Eriksson, Ulf;
Bredberg, Ulf;
Teger-Nilsson, Ann-Catrine

Publication type:

Article

Nuclear receptors: Growing concern for tamoxifen.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 647, doi. 10.1038/nrd1474

By:

Owens, Joanna

Publication type:

Article

Fragment-based lead discovery.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 660, doi. 10.1038/nrd1467

By:

Rees, David C.;
Congreve, Miles;
Murray, Christopher W.;
Carr, Robin

Publication type:

Article

Drug repositioning: identifying and developing new uses for existing drugs.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 673, doi. 10.1038/nrd1468

By:

Ashburn, Ted T.;
Thor, Karl B.

Publication type:

Article

Autoimmune diabetes: NKG2D receptor: a therapeutic target?

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 646, doi. 10.1038/nrd1475

By:

Brazil, Melanie

Publication type:

Article

Anticancer drugs: Taking out the chaperone.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 646, doi. 10.1038/nrd1476

By:

Kirkpatrick, Peter

Publication type:

Article

Statins: Target audience.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 648, doi. 10.1038/nrd1477

By:

Frantz, Simon

Publication type:

Article

Antiviral Drugs: Third strike against HIV enzymes.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 645, doi. 10.1038/nrd1480

By:

Kirkpatrick, Peter

Publication type:

Article

Hoping for the mother of all mergers.

Published in:: 2004
Publication type:: Editorial

Training academic chemists for industry.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 719, doi. 10.1038/nrd1483

By:

Frantz, Simon

Publication type:

Article

Francis S. Collins.

Published in:

2004

By:

Collins, Francis S.

Publication type:

Interview

Reach-through claims: how far a reach?

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 639, doi. 10.1038/nrd1491

By:

Becker, Daniel M.

Publication type:

Article

In Brief.

Published in:: Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 648, doi. 10.1038/nrd1479
Publication type:: Article